NURR1 involvement in recombinant tissue-type plasminogen activator treatment complications after ischemic stroke.
about
One-Compound-Multi-Target: Combination Prospect of Natural Compounds with Thrombolytic Therapy in Acute Ischemic Stroke.Potential biomarkers for predicting hemorrhagic transformation of ischemic stroke.Danshen-Chuanxiong-Honghua Ameliorates Cerebral Impairment and Improves Spatial Cognitive Deficits after Transient Focal Ischemia and Identification of Active Compounds.Isoquercetin Ameliorates Cerebral Impairment in Focal Ischemia Through Anti-Oxidative, Anti-Inflammatory, and Anti-Apoptotic Effects in Primary Culture of Rat Hippocampal Neurons and Hippocampal CA1 Region of Rats.New thrombolytic strategy providing neuroprotection in experimental ischemic stroke: MMP10 alone or in combination with tissue-type plasminogen activator.
P2860
NURR1 involvement in recombinant tissue-type plasminogen activator treatment complications after ischemic stroke.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
NURR1 involvement in recombina ...... cations after ischemic stroke.
@en
type
label
NURR1 involvement in recombina ...... cations after ischemic stroke.
@en
prefLabel
NURR1 involvement in recombina ...... cations after ischemic stroke.
@en
P2093
P50
P1433
P1476
NURR1 involvement in recombina ...... ications after ischemic stroke
@en
P2093
Anna Rosell
Audrey Le Béhot
Caty Carrera
Cristina Merino-Zamorano
Dolors Giralt
Isabelle Bardou
Mireia Parés
P304
P356
10.1161/STROKEAHA.114.006826
P407
P50
P577
2014-12-11T00:00:00Z